subject: Chronic Prostatitis - The Drawback of Oral Antibiotics [print this page] Chronic Prostatitis - The Drawback of Oral Antibiotics
Just mention Chronic Prostatitis and the word Ciproxin is inextricably linked. Such is the close association given to the drug. A diagnosis of Chronic Prostatitis almost certainly means an automatic prescription of Ciproxin. And there's the drawback, as this is an application of a very effective drug in a very ineffective delivery mechanism.
Ciproxin, (ciprofloxacin) is an excellent antibiotic to target prostate-based pathogens. It is usually well-tolerated by its users and usually offers a vast improvement in the patient's condition... but also usually only for a short time. Oral delivery of antibiotics to the prostate and surrounding tissues is the problem. The antibiotic is not delivered in sufficient strength to fully eradicate pathogens. So that vast improvement is usually short-lived. Worse, the antibiotics course may be re-tried many times over a long period of time resulting in the pathogen(s) losing sensitivity to the drug. All the while, the repeated courses are killing off good agents in the body and slowly damaging the immune system.
So, what's a better way? Injections to the perineal area are capable of delivering the required concentrations of the particular antibiotic being used. Moreover, the injection has the benefit of targeting particular tissues in the perineal area, and as the drugs are locally delivered, they'll not course around the body in any strength causing damage of beneficial bacteria.
So, where's the catch? Intraprostatitic injections are practiced by few Doctors, in spite of their apparent benefits and little extensive research has been done. A Chronic Prostatitis patient should have access to all forms of viable treatment. A lack of research should not preclude a technique as necessarily being unusable, and indeed there are several Clinics around the world which are making great progress in curing patients by direct injections of antibiotics. Find out more below.
